News and Updates

Latest updates and exciting news,

Helping you gain a comprehensive understanding of Xinwang Technology.

Zhishu Technology | Hu Yinfu: Crossing the Inflection Point, Advocating for Technological Innovation and Breakthroughs in Domestic CT X-ray Tubes

2025-05-13


On May 9–10, the 2025 VBEF Top 100 Future Healthcare and Pharmaceutical Exhibition was held at the Suzhou International Expo Center. The event brought together representatives from across the country, including leading upstream component manufacturers, medical device CDMO/CXO firms, research institutions, investment organizations, and industrial parks. Industry-leading experts convened to discuss cutting-edge technologies, emerging trends, and market opportunities.

As a specially invited enterprise, Mr. Hu YinFu, General Manager of Zhishu Technology, attended the sub‑forum of the “Medical Device Design and Manufacturing Conference” held on the 9th and delivered a keynote speech titled “Technological Innovation and Breakthroughs in Domestically Produced CT X‑ray Tubes.” He reviewed the company’s remarkable journey as the first in China to master liquid‑metal bearing technology for medical CT tubes, shared his in‑depth reflections on industry trends and the evolving landscape of collaborative models, and engaged in a roundtable discussion with leading experts. In response to the rapid transformation of global medical imaging technologies, Zhishu Technology put forward innovative proposals that integrate cutting‑edge technologies with new industry paradigms.

Despite the robust growth of China’s upstream medical imaging equipment industry, a gap remains compared with international advanced standards. In terms of both the depth and breadth of R&D and the competitiveness of high-end products in the global market, domestic companies must continue to strengthen their efforts. Throughout this process, technological innovation remains the core driving force behind the industry’s development.

Zhishu Technology regards technological innovation and the integration of industry, academia, and research as the cornerstone for scaling up mass production of liquid-metal bearing technology for domestically produced CT X-ray tubes. By establishing a comprehensive support system that encompasses an upstream–downstream industrial ecosystem, an intelligent manufacturing framework, 24/7 customer service, and a diversified product portfolio, the company has set a new industry benchmark in technology.

Hu Yinfu, General Manager of Zhishu Technology, emphasized at the conference:
“After more than four decades of dedicated development, China’s medical imaging companies have achieved a significant leap—from catching up technologically to overtaking competitors in the market. Zhishu Technology continues to ramp up R&D investment, leveraging its independent innovation capabilities to deepen domestic‑oriented collaboration across the upstream supply chain and steadily advance its global expansion strategy. Technological innovation not only fuels corporate growth but also creates powerful momentum for the rapid development of China’s multi‑hundred‑billion‑yuan imaging market.”
In 2020, Zhishu Technology successfully developed the first experimental liquid-metal‑bearing CT tube. In 2021, it obtained China’s first medical device registration certificate for a liquid-metal‑bearing CT tube, laying the groundwork for mass production. Since then, through continuous technological advancements, its high‑end medical CT tube products have successively received regulatory approvals, establishing a diversified product portfolio that serves both the original‑equipment market and the replacement‑market segments.

During the exhibition, ZhiShu Technology’s flagship products, the ZS702L and H847B, were awarded the “9th VBEF Future Healthcare Top 100 – Innovative Value Product/Solution” prize by Arterial Network. This prestigious honor not only underscores the company’s strength but also reflects ZhiShu Technology’s strategic shift in the medical innovation sector—from “follow‑on innovation” to “original‑source innovation.”

Looking ahead, Zhisu Technology will continue to ramp up investment in cutting-edge R&D, with a domestic component‑sourcing rate now reaching 95%, thereby achieving independent control over critical components. This ensures the reliable and stable operation of CT systems and provides robust support for their performance. By collaborating closely with industry partners, the company is driving cost reductions and efficiency gains in CT equipment, making high‑end imaging solutions more affordable and accessible to grassroots hospitals.